Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes
Pharmacogenetics: Sequencing finds DNA variants affecting chemoprevention response DNA sequencing has revealed genetic variants that explain inherited variation in responses to preventative drug therapy for breast cancer. Richard Weinshilboum from the Mayo Clinic in Rochester, Minnesota, USA, and co...
Guardado en:
Autores principales: | Duan Liu, Ming-Fen Ho, Daniel J. Schaid, Steven E. Scherer, Krishna Kalari, Mohan Liu, Joanna Biernacka, Vivien Yee, Jared Evans, Erin Carlson, Matthew P. Goetz, Michiaki Kubo, D. Lawrence Wickerham, Liewei Wang, James N. Ingle, Richard M. Weinshilboum |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56c8ccff590441f0a7e69f6365d4c7bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acta Nº423
por: Banco Central de Chile
Publicado: (2019) -
The pharmacogenomics journal
Publicado: (2001) -
Pharmacogenomics and Personalized Medicine
Publicado: (2009) -
Chapter 7: Pharmacogenomics.
por: Konrad J Karczewski, et al.
Publicado: (2012) -
Pharmacogenomics of hyaluronic acid
por: Elena E. Vaiman, et al.
Publicado: (2021)